Neurocrine Biosciences (Brazil) Technical Analysis
| N1BI34 Stock | 36.16 0.49 1.37% |
As of the 25th of November, Neurocrine Biosciences secures the Risk Adjusted Performance of (0.04), standard deviation of 2.83, and Mean Deviation of 1.35. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neurocrine Biosciences, as well as the relationship between them.
Neurocrine Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neurocrine, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeurocrineNeurocrine |
Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Neurocrine Biosciences Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Neurocrine Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Neurocrine Biosciences Trend Analysis
Use this graph to draw trend lines for Neurocrine Biosciences. You can use it to identify possible trend reversals for Neurocrine Biosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Neurocrine Biosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Neurocrine Biosciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Neurocrine Biosciences applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Neurocrine Biosciences will continue generating value for investors. It has 122 observation points and a regression sum of squares at 49.51, which is the sum of squared deviations for the predicted Neurocrine Biosciences price change compared to its average price change.About Neurocrine Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neurocrine Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neurocrine Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neurocrine Biosciences price pattern first instead of the macroeconomic environment surrounding Neurocrine Biosciences. By analyzing Neurocrine Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neurocrine Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neurocrine Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
Neurocrine Biosciences November 25, 2024 Technical Indicators
Most technical analysis of Neurocrine help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurocrine from various momentum indicators to cycle indicators. When you analyze Neurocrine charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.74) | |||
| Mean Deviation | 1.35 | |||
| Coefficient Of Variation | (1,788) | |||
| Standard Deviation | 2.83 | |||
| Variance | 8.02 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.75) | |||
| Maximum Drawdown | 19.0 | |||
| Value At Risk | (3.04) | |||
| Potential Upside | 3.5 | |||
| Skewness | (2.94) | |||
| Kurtosis | 22.36 |
Complementary Tools for Neurocrine Stock analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |